Bilcare Ltd (BI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bilcare Ltd on NSE and BSE, with an AI summary of each filing.
The Board of Directors has approved the Financial Results for quarter and half year ended September 30, 2026
Financial Result · 04 Nov 2026, 3:18 am
The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial Results of ....
Outcome · 04 Nov 2026, 3:08 am
Bilcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 248 (+39.4% YoY | +10.0% QoQ) ■ EBITDA: 22.3 (+552.3% YoY | -39.7% QoQ) ■ EBITDA Margin (%): 9.0 (+706 bps YoY | -741 bps QoQ) ■ PAT: 4.1 (Loss to Profit YoY | -67.6% QoQ) ■ EPS (INR): 1.75 (Loss to Profit YoY | -67.5% QoQ)
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Bilcare Limited has informed BSE that ....
Intimation · 03 Nov 2026, 5:30 am
Bilcare Board Meeting Scheduled for Nov'26 to Consider Q2 Results Bilcare Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will remain shut until 48 hours following the official declaration of the financial results.
Update on Voluntary winding up of Bilcare INC -US
Others (Uncategorized) · 20 Oct 2026, 12:34 am
Bilcare Limited Completes Voluntary Dissolution of US Subsidiary Bilcare Limited announced the voluntary winding up and dissolution of its wholly owned US subsidiary, Bilcare Inc US, effective 9th Sep'26, pursuant to a Certificate of Dissolution dated 16th Sep'26. The dissolved entity was a non-material subsidiary and reported nil turnover for FY26, resulting in zero impact on Bilcare Limited's consolidated revenues or ongoing business operations.
Change in Designation of Mr. Mohan Bhandari and Ms Kavita Bhansali
Change in Management · 15 Oct 2026, 10:55 pm
Bilcare Reverts Executive Appointments Following Shareholder Rejection at 39th AGM Bilcare Limited announced that special resolutions proposed at its 39th AGM on 26th Sep'26 to appoint Mohan Bhandari and reappoint Kavita Bhansali as Executive Directors failed to secure the requisite majority. Consequently, Mohan Bhandari continues solely as Non-Executive Non-Independent Director & CEO, while Kavita Bhansali continues as Non-Executive Non-Independent Director. The designations will be updated accordingly on BSE records, reversing board approvals previously made on 13th Aug'26.
Voting Results of 39th Annual General Meeting and Scrutinizers Reports
Annual General Meeting · 30 Sept 2026, 1:07 am
Bilcare Limited has informed the exchange about Proceeding of 39th Annual General Meeting held on 26 September 2026
Annual General Meeting · 27 Sept 2026, 12:41 am
Bilcare Limited has submitted to Stock Exchange the Corrigendum to item No. 4 of the Notice of the 39th Annual General Meeting
Annual General Meeting · 24 Sept 2026, 11:02 pm
Bilcare Limited has submitted to Stock Exchange the Corrigendum to Item No. 4 of the Notice of the 39th Annual General Meeting
Annual General Meeting · 24 Sept 2026, 10:33 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Anuradha & Others
Acquisition/ Disposal of Shares · 21 Sept 2026, 5:46 pm
Guttikonda Group Acquires 2.01% Stake in Bilcare Limited via Open Market Guttikonda Anuradha, Guttikonda Vara Lakshmi, and Guttikonda Rajasekhar (PACs, Non-Promoter) acquired 4,73,264 equity shares, representing a 2.01% stake, in Bilcare Limited on 17th Sep'26 via open market purchases. The transaction comprised acquisitions by Guttikonda Vara Lakshmi (3,12,464 shares or 1.33%) and Guttikonda Rajasekhar (1,60,800 shares or 0.68%). Following this transaction, the collective shareholding of the acquirers increased from 34,03,380 shares (14.46%) to 38,76,944 shares (16.47%) of the company's total voting capital of Rs. 23,54,52,310 (comprising 2,35,45,231 equity shares).
Bilcare Limited has submitted Outcome of Board Meeting
Others (Uncategorized) · 05 Sept 2026, 4:54 am
Bilcare Limited has submitted to the Exchange it''s Annual Report of 2025-26
Others (Uncategorized) · 05 Sept 2026, 4:51 am
Bilcare Limited has submitted to the Exchnage Annual Report of 2025-26.
Annual General Meeting · 05 Sept 2026, 4:48 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar & Others
Acquisition/ Disposal of Shares · 22 Aug 2026, 4:08 pm
Bilcare: Non-Promoter Entities Sell 2.61% Stake via Open Market Guttikonda Vara Lakshmi and Guttikonda Rajasekhar, non-promoter entities, collectively sold 6,15,180 shares (2.61% of diluted capital) in Bilcare Limited via an open market transaction on 19th Aug'26. Guttikonda Vara Lakshmi sold 5,79,837 shares (2.46% stake), and Guttikonda Rajasekhar sold 35,343 shares (0.15% stake). Their combined holding subsequently decreased from 17.07% to 14.46%. Guttikonda Anuradha’s stake remained unchanged at 0.14%. The disclosure was filed under SEBI SAST regulations on 21st Aug'26.
Bilcare Limited has informed the Exchange about the Voluntary winding up of wholly owned subsidiary.
Others (Uncategorized) · 14 Aug 2026, 4:58 am
Bilcare Q1FY27 Results, Board Changes, and Subsidiary Wind-Up Bilcare reported Q1FY27 consolidated net profit of ₹14.97 Cr, a significant turnaround from a loss of ₹2.84 Cr YoY. Revenue from operations grew 21% YoY to ₹225.86 Cr. The board approved results on 13 Aug'26, alongside key management changes. This includes appointing founder Mr. Mohan Bhandari as an Executive Director and reappointment of Ms. Kavita Bhansali as ED. The Company Secretary has resigned, with Mr. Mayur Dave appointed as successor. Additionally, the board approved the voluntary winding-up of its non-material US subsidiary, Bilcare INC.
Bilcare Limited has informed the Exchange about the appointment of Company Secretary, Compliance Officer and Key Managerial Personnel
Change in Management · 14 Aug 2026, 4:55 am
Bilcare Reports Q1FY27 Results and Key Leadership Changes Bilcare reported Q1FY27 consolidated net profit of ₹14.97 Cr, a significant turnaround from a loss of ₹2.84 Cr YoY. Revenue from operations grew 21.2% YoY to ₹225.86 Cr. Standalone PAT was ₹1.04 Cr versus ₹3.59 Cr YoY. The board, in its meeting on 13 Aug'26, also approved key leadership changes: Mr. Mohan Bhandari was appointed Executive Director and Ms. Kavita Bhansali was reappointed Executive Director. Further, Mr. Sagar Baheti resigned as Company Secretary, with Mr. Mayur Dave appointed as his successor effective 25 Sep'26.
Bilcare Limited has informed the Exchange aabout the Resignation of Company Secretary, Compliance Officer and Key Managerial Personnel
Change in Management · 14 Aug 2026, 4:53 am
Bilcare: Q1FY27 Results, Director Changes, and Winding Up of US Subsidiary Bilcare’s board approved Q1FY27 results on 13 Aug'26. On a consolidated basis, revenue from operations was ₹225.86 Cr, up 21.2% YoY, and Net Profit stood at ₹14.97 Cr versus a loss of ₹2.84 Cr YoY. The board also appointed Mohan Bhandari as Executive Director, reappointed Kavita Bhansali as Executive Director, and approved the resignation of Company Secretary Sagar Baheti, appointing Mayur Dave as his successor. Additionally, the board approved the voluntary winding up of Bilcare INC, a non-material wholly-owned US subsidiary.
Bilcare Limited has informed the Exchange about the appointment of Mr. Mohan Bhandari as an Executive Director of the Company and reappointment of Ms. Kavita Bhansali as Executive Director ....
Change in Management · 14 Aug 2026, 4:48 am
Bilcare Board Approves Q1FY27 Results and Key Management Changes For Q1FY27 (ended 30 Jun'26), Bilcare reported consolidated revenue of ₹225.86 Cr, up 21.0% YoY, with PAT at ₹12.70 Cr versus a loss of ₹6.03 Cr YoY. The board approved results on 13 Aug'26 and key management changes, including appointing Mohan Bhandari and reappointing Kavita Bhansali as Executive Directors. It also noted the resignation of Sagar R. Baheti as Company Secretary and appointed Mayur Dave as his successor. Additionally, the board approved the voluntary winding up of its non-material US subsidiary, Bilcare INC.
Bilcare Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued by Statutory ....
Financial Result · 14 Aug 2026, 4:43 am
Bilcare Q1FY27 Results & Key Board Decisions Bilcare reported Q1FY27 consolidated net profit of ₹12.7 Cr versus a loss of ₹6.03 Cr YoY. Revenue from operations grew 21% YoY to ₹225.86 Cr. Standalone PAT was ₹1.04 Cr against ₹3.59 Cr YoY. The board approved Q1 results, the appointment of Mr. Mohan Bhandari as Executive Director, and the reappointment of Ms. Kavita Bhansali as ED. Mr. Mayur Dave was appointed Company Secretary following Mr. Sagar Baheti's resignation. The board also proposed the voluntary winding up of its non-material US subsidiary, Bilcare INC.
Bilcare Limitedhas informed the Exchange about the outcome of Board Meeting.
Outcome · 14 Aug 2026, 4:24 am
Bilcare Q1FY27 Results, Board Changes, and Subsidiary Winding Up Bilcare reported Q1FY27 consolidated net profit of ₹14.97 Cr, reversing a loss of ₹2.84 Cr YoY, on revenue of ₹225.86 Cr (+21.2% YoY). The board approved results, the appointment of Mr. Mohan Bhandari as Executive Director, and the reappointment of Ms. Kavita Bhansali as Executive Director. Mr. Sagar Baheti resigned as Company Secretary, with Mr. Mayur Dave appointed as his successor. The board also approved the voluntary winding up of its non-material US subsidiary, Bilcare INC, which had NIL turnover in FY26.
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....
Intimation · 13 Aug 2026, 5:30 am
Bilcare Schedules Board Meeting to Approve Q1FY27 Financials Bilcare Limited will hold a Board of Directors meeting on 13 Aug'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended 30 Jun'26. The trading window for designated persons has been closed from 01 Jul'26 and will reopen 48 hours after the results are declared. This action complies with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions, 2015 - Order of Hon''ble ....
Others (Uncategorized) · 13 Jun 2026, 1:38 am
Bilcare Receives NCLT Order Condoning Delay in Fixed Deposit Repayment The NCLT Mumbai Bench, in its order dated 05 Jun'26, has condoned Bilcare's delay in repaying public fixed deposits. The company, which had accepted deposits of Rs. 171.28 crore, has already repaid Rs. 168.76 crore. A balance of Rs. 2.52 crore remains outstanding for 542 deposit holders. The NCLT has directed Bilcare to deposit the outstanding principal and accrued interest into the Investor Education and Protection Fund (IEPF) by 15 Jul'26 and to notify unpaid depositors about the claims process by 31 Jul'26.
Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others (Uncategorized) · 05 Jun 2026, 3:05 am
Bilcare to Forfeit Rs. 1.57 Crore on Warrants in Caprihans India Bilcare Limited's Board has decided not to exercise its option to convert 3,15,000 warrants in Caprihans India Limited. The decision, made on 4th Jun'26, cites the company's liquidity position and capital allocation priorities. Consequently, the warrants will lapse, and the upfront subscription payment of Rs. 1,57,50,000 will be forfeited. The exercise period for the warrants expires on 4th Jun'26. This move reflects a strategic shift in capital use, resulting in a direct financial write-off for Bilcare.
Bilcare Limited has informed the Exchange about the following: a) Redemption of Preference Shares and b) Conversion of Warrants and Allotment of Equity Shares
Others (Uncategorized) · 30 May 2026, 8:39 am
Bilcare Reports Q4 Standalone Loss, Converts Warrants in Caprihans India Bilcare reported a Q4 FY26 standalone net loss of ₹6.35 crore, a significant decline from a ₹3.36 crore profit YoY. Total income fell 52.5% YoY to ₹5.02 crore. For the full year, net profit was ₹0.99 crore versus ₹3.99 crore in FY25. The Board did not recommend a dividend. Bilcare also converted 10,40,000 warrants in Caprihans India, increasing its stake to 62.04% by 29 May'26. Additionally, it redeemed 1,56,00,000 preference shares of Caprihans India for an aggregate of ₹15.60 crore.
Bilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results (Standalone and Consolidated) for the ....
Financial Result · 30 May 2026, 8:33 am
Bilcare Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Crore) ■ Revenue: 188 (-3.3% YoY | +3.5% QoQ) ■ EBITDA: 16.9 (+120.4% YoY | +30.1% QoQ) ■ EBITDA Margin (%): 9.0 (+506 bps YoY | +185 bps QoQ) ■ PAT: 13.4 (-23.9% YoY | +1278.4% QoQ) ■ EPS (INR): 5.68 (-24.0% YoY | +1285.4% QoQ)